1Departments of Medicine and Pathology, Section of Rheumatology, Committee on Immunology, University of Chicago, Chicago, IL 60637, USA.
Disrupting the B-cell antigen receptor (BCR) association with Src-family tyrosine kinases (SFTKs) using Igalpha/M or Igbeta/M analogs reduced BCR signaling. Igalpha/M specifically attenuated tyrosine phosphorylation and apoptosis.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: